1 day Oramed Pharmaceuticals (NASDAQ:ORMP) Cut to “Hold” at StockNews.comMarketBeat
StockNews.com lowered shares of Oramed Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Monday.
Nasdaq 100 · Pharmaceuticals · Science
X